PL2035457T3 - Nośnik szczepionki - Google Patents

Nośnik szczepionki

Info

Publication number
PL2035457T3
PL2035457T3 PL07718492T PL07718492T PL2035457T3 PL 2035457 T3 PL2035457 T3 PL 2035457T3 PL 07718492 T PL07718492 T PL 07718492T PL 07718492 T PL07718492 T PL 07718492T PL 2035457 T3 PL2035457 T3 PL 2035457T3
Authority
PL
Poland
Prior art keywords
vaccine carrier
vaccine
carrier
Prior art date
Application number
PL07718492T
Other languages
English (en)
Inventor
Rudolf Valenta
Margarete Focke-Tejkl
Birgit Linhart
Susanne Vrtala
Peter Valent
Renate Reininger
Susanne Spitzauer
Ines Swoboda
Hage Marianne Van
Hans Grönlund
Johanna Tinhofer
Kerstin Westritschnig
Theresia Popow-Kraupp
Original Assignee
Biomay Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomay Ag filed Critical Biomay Ag
Publication of PL2035457T3 publication Critical patent/PL2035457T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32711—Rhinovirus
    • C12N2770/32734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07718492T 2006-06-09 2007-06-11 Nośnik szczepionki PL2035457T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0099406A AT503690A1 (de) 2006-06-09 2006-06-09 Hypoallergene moleküle
EP07718492.7A EP2035457B1 (en) 2006-06-09 2007-06-11 Vaccine carrier
PCT/AT2007/000281 WO2007140505A2 (en) 2006-06-09 2007-06-11 Vaccine carrier

Publications (1)

Publication Number Publication Date
PL2035457T3 true PL2035457T3 (pl) 2015-10-30

Family

ID=38650124

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07718492T PL2035457T3 (pl) 2006-06-09 2007-06-11 Nośnik szczepionki

Country Status (14)

Country Link
US (2) US9296828B2 (pl)
EP (2) EP2924047B1 (pl)
JP (3) JP5399895B2 (pl)
CN (3) CN103319601A (pl)
AT (1) AT503690A1 (pl)
AU (1) AU2007257308B2 (pl)
BR (1) BR122019004393B1 (pl)
CA (1) CA2657971C (pl)
DK (2) DK2035457T3 (pl)
ES (2) ES2541311T3 (pl)
PL (1) PL2035457T3 (pl)
PT (1) PT2035457E (pl)
RU (1) RU2486206C2 (pl)
WO (1) WO2007140505A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0815395A2 (pt) 2007-08-15 2015-02-10 Circassia Ltd Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição.
EP2153841B2 (en) * 2008-08-15 2015-11-11 Circassia Limited Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
WO2010076583A1 (en) * 2008-12-30 2010-07-08 Kaw Yan Chua A variant of mite allergen and uses thereof
CO6260019A1 (es) * 2009-01-30 2011-03-22 Fundacion Universidad Del Norte Metodo y composicion inmunoquimica para la deteccion de alergenos de acaros usando anticuerpos policlonales igy
AU2013202362B2 (en) * 2009-02-05 2015-09-17 Circassia Limited Grass Peptides for Vaccine
SI2393830T1 (sl) * 2009-02-05 2015-04-30 Circassia Limited Travni peptidi za cepivo
EP2316481A1 (en) * 2009-10-30 2011-05-04 Biomay Ag Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
PT2717910T (pt) * 2011-06-09 2019-05-22 Biomay Ag Proteínas de fusão transportadoras de péptido como vacinas para alergia
EP2723373B1 (en) * 2011-06-27 2017-06-21 Anergis S.A. Contiguous overlapping peptides for treatment of ragweed pollen allergy
EP2543725A1 (en) 2011-07-08 2013-01-09 Biomay Ag Polysaccharide lyases
JO3820B1 (ar) 2012-05-03 2021-01-31 Regeneron Pharma أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها
GB201209868D0 (en) * 2012-06-01 2012-07-18 Circassia Ltd Alternaria peptides
US9163069B2 (en) 2012-09-20 2015-10-20 Universidad De Cartagena Fusion proteins representing different allergens and a vaccine against allergy to mites
JP2014231500A (ja) * 2013-05-29 2014-12-11 元晴 植原 シラカンバ花粉症の免疫療法に用いるペプチド混合物
EP3036543B1 (en) 2013-08-23 2019-06-19 Regeneron Pharmaceuticals, Inc. Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit)
WO2017004561A1 (en) * 2015-07-01 2017-01-05 Alk-Abelló A/S Peptide combinations and uses thereof for treating grass allergy
PL3558347T3 (pl) 2016-12-22 2026-04-20 Regeneron Pharmaceuticals, Inc. Sposób leczenia alergii swoistymi dla alergenu przeciwciałami monoklonalnymi
US11408895B1 (en) 2018-04-09 2022-08-09 Hob Biotech Group Corp., Ltd. Allergen characterization, potent allergen product formulation, comprehensive allergen reagent, and allergy assay
EP3569612A1 (en) * 2018-05-18 2019-11-20 Biomay Ag Treatment and prevention of house dust mite allergies
RU2761431C9 (ru) 2020-10-26 2022-04-18 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Рекомбинантный полипептид на основе аллергена пыльцы березы и аллергена яблока в качестве вакцины от аллергии

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
GB8821077D0 (en) 1988-09-08 1988-10-05 Wellcome Found Peptides
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6019972A (en) * 1989-11-03 2000-02-01 Immulogic Pharmaceutical Corporation Peptides of human T cell reactive feline protein (TRFP)
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
DE69233482T2 (de) 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
IL103456A (en) * 1991-10-16 2006-06-11 Merck Patent Gmbh Isolated peptides having t-cell stimulating activity
IL105153A (en) * 1992-03-25 1999-12-22 Immulogic Pharma Corp Therapeutic compositions comprising peptides derived from human t cell reactive feline protein
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
AT401937B (de) * 1993-04-01 1996-12-27 Biomay Prod & Handel Rekombinantes lieschgras pollen allergen phl p ii
JPH09501043A (ja) * 1993-04-14 1997-02-04 イミュロジク ファーマスーティカル コーポレイション Ｄｅｒｍａｔｏｐｈａｇｏｉｄｅｓ（室内塵ダニ）由来の主要アレルゲンのｔ細胞エピトープ
JPH09512014A (ja) * 1994-04-14 1997-12-02 イミユロジク・フアーマシユーチカル・コーポレーシヨン ダニアレルギー治療用の医薬ペプチド組成物
SE9402089D0 (sv) * 1994-06-14 1994-06-14 Rudolf Valenta Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
US6572859B1 (en) * 1999-10-29 2003-06-03 Pharmacia Diagnostics Ab Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use
US20030166518A1 (en) * 2000-01-13 2003-09-04 Beardslee Thomas A. Method for allergen characterization
ATE418997T1 (de) 2000-07-06 2009-01-15 Univ Georgetown Stabile (fixierte) formen von viralen l1 capsidproteinen, deren fusionsproteinen, und deren verwendungen
ES2209563B1 (es) 2000-07-28 2005-10-01 Universidad Complutense De Madrid Produccion en la levadurapipchia pastoris y sistema de purificacion del alergeno recombinante de olea europaea ole e 1 para uso en diagnosis y tratamiento de alergias.
PL214225B1 (pl) * 2000-11-16 2013-07-31 Alk Abello As Zrekombinowany alergen, zastosowanie zrekombinowanego alergenu, kompozycja farmaceutyczna, sposób przygotowania kompozycji farmaceutycznej, sposób przygotowania zrekombinowanego alergenu, sekwencja DNA kodujaca zrekombinowany alergen, wektor ekspresyjny, komórka gospodarza oraz sposób produkcji zrekombinowanego zmutowanego alergenu
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
PT1478662E (pt) * 2002-02-27 2009-12-29 Merck Patent Gmbh Método para o fabrico do alergeno principal do pólen de bétula hipoalergénico rbet v 1
US20060121468A1 (en) * 2002-06-26 2006-06-08 Allnutt F C T Viruses and virus-like particles for multiple antigen and target display
MXPA05000287A (es) 2002-07-05 2005-09-08 Leclerc Denis Particula viral adyuvante.
ES2247433T3 (es) 2003-01-21 2006-03-01 Biomay Produktions- Und Handels- Aktiengesellschaft Procedimiento para la preparacion de proteinas de mosaico hipoalergenicas.
GB0308988D0 (en) * 2003-04-17 2003-05-28 Univ Singapore Molecule
JP4782671B2 (ja) * 2003-06-04 2011-09-28 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 低減したアレルギー誘発性および保持されたＴ細胞反応性を有するＰｈｌｐ５ａ誘導体
US20050053615A1 (en) * 2003-07-16 2005-03-10 Best Elaine A. Variants of mite group 1 allergens for the treatment of house dust mite allergy
DE10351471A1 (de) * 2003-11-04 2005-06-09 Ursula Prof. Dr. Wiedermann-Schmidt Polyvalente Allergievakzine
CA2547511A1 (en) * 2003-12-01 2005-07-28 Dow Global Technolgies Inc. Recombinant icosahedral virus like particle production in pseudomonads
WO2005086667A2 (en) * 2004-02-27 2005-09-22 The Dow Chemical Company High efficiency peptide production in plant cells
ITRM20040103A1 (it) * 2004-02-27 2004-05-27 Consiglio Nazionale Ricerche Proteine di fusione comprendenti allergeni della famiglia delle ns-ltps, loro usi e composizioni farmaceutiche che le comprendono.
US20060088549A1 (en) * 2004-07-08 2006-04-27 Arnold Gail F Chimeric virus vaccine
DE102004035337A1 (de) * 2004-07-21 2006-03-16 Merck Patent Gmbh Varianten der Gruppe 1-Allergene aus Poaceae mit reduzierter Allergenität und erhaltener T-Zellreaktivität
NZ554387A (en) * 2004-09-21 2009-09-25 Cytos Biotechnology Ag Virus-like particles comprising a fusion protein of the coat protein of AP205 and an antigenic polypeptide
AT501101B1 (de) * 2004-12-02 2008-01-15 Biomay Ag Protein-allergen-derivat
ES2424229T3 (es) * 2005-03-18 2013-09-30 Cytos Biotechnology Ag Proteínas de fusión de alérgenos de gato y utilización de las mismas
EP2228656B1 (en) * 2005-09-15 2013-10-23 Alk-Abelló A/S Quantification of allergens

Also Published As

Publication number Publication date
US9296828B2 (en) 2016-03-29
JP2009539354A (ja) 2009-11-19
CA2657971C (en) 2018-01-23
ES2541311T3 (es) 2015-07-17
BR122019004393B1 (pt) 2023-10-17
US20160257722A1 (en) 2016-09-08
JP5399895B2 (ja) 2014-01-29
WO2007140505A3 (en) 2008-03-20
AU2007257308A1 (en) 2007-12-13
EP2924047B1 (en) 2018-08-22
CA2657971A1 (en) 2007-12-13
CN103319601A (zh) 2013-09-25
EP2924047A1 (en) 2015-09-30
CN101466738A (zh) 2009-06-24
WO2007140505A2 (en) 2007-12-13
JP2014064573A (ja) 2014-04-17
JP2014087341A (ja) 2014-05-15
CN103319602B (zh) 2016-09-07
US20090324501A1 (en) 2009-12-31
BRPI0712421A2 (pt) 2012-06-19
AT503690A1 (de) 2007-12-15
RU2486206C2 (ru) 2013-06-27
RU2008152045A (ru) 2010-07-20
DK2035457T3 (en) 2015-06-15
EP2035457B1 (en) 2015-04-01
DK2924047T3 (en) 2018-12-03
EP2035457A2 (en) 2009-03-18
ES2698525T3 (es) 2019-02-05
AU2007257308B2 (en) 2013-06-06
PT2035457E (pt) 2015-07-28
CN103319602A (zh) 2013-09-25

Similar Documents

Publication Publication Date Title
GB0607088D0 (en) Vaccine
GB0711858D0 (en) Vaccine
DE602007006989D1 (en) Spiropiperidinderivate
GB0616306D0 (en) Vaccines
ZA200902155B (en) IPV-DPT vaccine
GB0710538D0 (en) Vaccine
GB0700135D0 (en) Vaccine
ZA200901592B (en) Vaccine
GB0614460D0 (en) Vaccines
GB0724772D0 (en) Carrier
GB0702229D0 (en) Carrier
GB0709373D0 (en) BCG-based anti-atheroma vaccine
GB0625593D0 (en) Vaccine
GB0622348D0 (en) Retaining means
GB0617450D0 (en) Liverstock carriers
TWI346426B (en) Carrier
GB0614254D0 (en) Vaccine
GB0619821D0 (en) Vaccine
GB0608962D0 (en) Vaccine
GB0620816D0 (en) vaccine
GB0606256D0 (en) Anti-atheroma vaccine
GB0619820D0 (en) Vaccine
GB0619824D0 (en) Vaccine
GB0620815D0 (en) Vaccine
GB0620336D0 (en) Vaccine